Table of Contents Author Guidelines Submit a Manuscript
Journal of Skin Cancer
Volume 2013 (2013), Article ID 423829, 8 pages
Review Article

Ipilimumab: A First-in-Class  T-Cell Potentiator for Metastatic Melanoma

Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA

Received 22 January 2013; Accepted 12 April 2013

Academic Editor: Sanjiv S. Agarwala

Copyright © 2013 Bartosz Chmielowski. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Bartosz Chmielowski, “Ipilimumab: A First-in-Class  T-Cell Potentiator for Metastatic Melanoma,” Journal of Skin Cancer, vol. 2013, Article ID 423829, 8 pages, 2013. doi:10.1155/2013/423829